Evidence map›Paper›PMID 29133307›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2017

The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E

Zora Djuric, D Kim Turgeon, Ananda Sen, Jianwei Ren, Kirk Herman, Devon Ramaswamy, Lili Zhao, Mack T Ruffin, Daniel P Normolle, William L Smith and 1 more

Open access · greenAbstract readClinical Trial, Phase I
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Effect ofJournal of nutritional science
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Zora DjuricDepartment of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan. zoralong@umich.edu.
D Kim TurgeonDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Ananda SenDepartment of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Jianwei RenDepartment of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Kirk HermanDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Devon RamaswamyDepartment of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Lili ZhaoDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Mack T RuffinDepartment of Family and Community Medicine, Penn State Hershey Medical Center, Hershey, Pennsylvania.
Daniel P NormolleDepartment of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
William L SmithDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan.
Dean E BrennerDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
University of Michigan–Ann Arbor · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Gary D Luker · 1988 to 2026
$178.2M
VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Dan Paul Zandberg · 1988 to 2026
$158.0M
Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Translational Research in GI CancerP50CA130810 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRENNER, DEAN E. · 2010 to 2016
$11.8M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Michigan Institute for Clinical and Health Research (MICHR) (KL2)KL2RR024987 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$2.8M
NCATS NIH HHS UL1 TR002240NCI NIH HHS P30 CA046592NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA130810NCRR NIH HHS KL2 RR024987NCRR NIH HHS UL1 RR024986NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK092926NIDDK NIH HHS P60 DK020572
6 · The paper itself

Abstract

This clinical trial developed a personalized dosing model for reducing prostaglandin E

Indexed as

AdultAgedAnti-Inflammatory AgentsArachidonic AcidBayes TheoremBiomarkersBody Mass IndexBody WeightCell ProliferationDinoprostoneEicosapentaenoic AcidFatty Acids, Omega-3Fatty Acids, Omega-6FemaleFish OilsHealthy VolunteersAnti-Inflammatory AgentsArachidonic AcidBiomarkersDinoprostoneEicosapentaenoic AcidFatty Acids, Omega-3Fatty Acids, Omega-6Fish Oils

Identifiers

PMID29133307
PMCPMC5767924
OpenAlexW2767346039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.